Fox Run Management, L.L.C. Omeros Corp Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$10.72 - $16.73 $186,088 - $290,416	-17,359 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$17.73 - $26.69 $307,775 - $463,311	17,359 New	17,359 $424,000
Q1 2018 Apr 17, 2018	SELL	$9.0 - $20.16 $233,550 - $523,152	-25,950 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$13.26 - $22.86 $344,097 - $593,217	25,950	25,950 $504,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.